Literature DB >> 2982920

The pathobiology of the osteoclast.

T J Chambers.   

Abstract

This article reviews recent information concerning the origin of osteoclasts and the local and systemic regulation of their activity. It appears that much of the environmental responsiveness of osteoclasts is mediated by cells of the osteoblastic lineage, which exert a major influence on the localisation, induction, stimulation, and inhibition of osteoclastic bone resorption. Some of the mechanisms by which osteoclast function may be disturbed by inflammatory and neoplastic diseases are discussed, and it is suggested that many pathological disturbances of osteoclastic bone resorption may be explicable as mimicry of physiological regulatory mechanisms by local hormones introduced into bone as the local regulators of the diseased tissue.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982920      PMCID: PMC499119          DOI: 10.1136/jcp.38.3.241

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  107 in total

1.  Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins.

Authors:  C S Galasko; A Bennett
Journal:  Nature       Date:  1976-10-07       Impact factor: 49.962

2.  Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

Authors:  A F Stewart; R Horst; L J Deftos; E C Cadman; R Lang; A E Broadus
Journal:  N Engl J Med       Date:  1980-12-11       Impact factor: 91.245

Review 3.  The origin of osteoclasts: evidence, clinical implications and investigative challenges of an extra-skeletal source.

Authors:  S C Marks
Journal:  J Oral Pathol       Date:  1983-08

4.  Pulsing electromagnetic fields: a new method to modify cell behavior in calcified and noncalcified tissues.

Authors:  C A Bassett
Journal:  Calcif Tissue Int       Date:  1982-01       Impact factor: 4.333

5.  Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3.

Authors:  Z Bar-Shavit; S L Teitelbaum; P Reitsma; A Hall; L E Pegg; J Trial; A J Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

6.  Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin.

Authors:  T J Powles; M Dowsett; G C Easty; D M Easty; A M Neville
Journal:  Lancet       Date:  1976-03-20       Impact factor: 79.321

7.  An interleukin 1 like factor stimulates bone resorption in vitro.

Authors:  M Gowen; D D Wood; E J Ihrie; M K McGuire; R G Russell
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

8.  The effect of prostaglandin synthesis inhibitors and diphosphonates on tumour-mediated osteolysis.

Authors:  C S Galasko; A W Samuel; S Rushton; E Lacey
Journal:  Br J Surg       Date:  1980-07       Impact factor: 6.939

9.  Some mechanisms of local bone destruction by squamous carcinomas of the head and neck.

Authors:  S W Tsao; J F Burman; D M Easty; G C Easty; R L Carter
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

10.  Prostaglandin-like material extracted from squamous carcinomas of the head and neck.

Authors:  A Bennett; R L Carter; I F Stamford; N S Tanner
Journal:  Br J Cancer       Date:  1980-02       Impact factor: 7.640

View more
  49 in total

1.  Paramyxovirus-like nuclear inclusions identical to those of Paget's disease of bone detected in giant cells of primary oxalosis.

Authors:  P Bianco; G Silvestrini; P Ballanti; E Bonucci
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Electron microscopy of developing calvaria reveals images that suggest that osteoclasts engulf and destroy osteocytes during bone resorption.

Authors:  A S Elmardi; M V Katchburian; E Katchburian
Journal:  Calcif Tissue Int       Date:  1990-04       Impact factor: 4.333

3.  Production and characterization of new monoclonal antibodies to human osteoclasts.

Authors:  P N Nelson; J A Pringle; T J Chambers
Journal:  Calcif Tissue Int       Date:  1991-11       Impact factor: 4.333

4.  Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function.

Authors:  N A Athanasou; J Quinn
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

Review 5.  Toward a cure for osteoporosis: reversal of excessive bone fragility.

Authors:  C H Turner
Journal:  Osteoporos Int       Date:  1991-10       Impact factor: 4.507

6.  Isolation of a murine osteoclast colony-stimulating factor.

Authors:  M Y Lee; D R Eyre; W R Osborne
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

7.  Local effects of impaired mechanical properties of collagen on bone formation and resorption.

Authors:  A Kwong-Hing; R Teasdale; H S Sandhu
Journal:  Anat Embryol (Berl)       Date:  1991

Review 8.  Historically significant events in the discovery of RANK/RANKL/OPG.

Authors:  T John Martin
Journal:  World J Orthop       Date:  2013-10-18

9.  Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

Authors:  I MacIntyre; M Zaidi; A S Alam; H K Datta; B S Moonga; P S Lidbury; M Hecker; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

10.  1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.

Authors:  P M McSheehy; T J Chambers
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.